Erschienen in:
11.08.2017 | Intractable Disease in the Elderly: When Conventional Therapy Fails (S Katz, Section Editor)
Intractable Constipation in the Elderly
verfasst von:
Noemi Baffy, MD, MPH, Amy E. Foxx-Orenstein, DO, Lucinda A. Harris, MD, Susan Sterler, RN
Erschienen in:
Current Treatment Options in Gastroenterology
|
Ausgabe 3/2017
Einloggen, um Zugang zu erhalten
Opinion statement
Chronic constipation is a common gastrointestinal disorder disproportionately affecting the elderly. Immobility, polypharmacy, and physiologic changes contribute to its increased prevalence in this population. Unidentified and undertreated constipation leads to a significant negative impact on quality of life and an increase in healthcare spending. Careful physical examination and exploration of the clinical history can unmask primary and secondary forms of constipation, guiding diagnostic and therapeutic considerations. Non-pharmacologic treatment options include bowel training and biofeedback as well as the addition of fiber. Laxatives are safe and can be used long term; thus, they remain the mainstay of therapy. Newer agents with specific physiologic targets have proven to be effective in adults with chronic constipation, but data is lacking for safety profile in the elderly. Consideration for surgery in medically refractory cases should be entertained, while use of neuromodulation is not ready for prime time. This is a review of the currently available treatment options for chronic constipation in adults and specifically tailored towards the elderly.